Searchable abstracts of presentations at key conferences in endocrinology

ea0081p643 | Endocrine-Related Cancer | ECE2022

Thyroid cancer and thalassemia major: new hypotheses from an old clinical scenario

Poggi Maurizio , Samperi Irene , Monti Salvatore , motta cecilia , Pugliese Giuseppe

Thyroid cancer (TC) is one of the most frequent neoplasia diagnosed in general population with an estimated incidence of 6.6 cases per 100.000 and mortality of 0.43 cases per 100.000. Differentiated thyroid cancer (DTC), which includes papillary (PTC) and follicular cancer (FTC), comprises the large majority (up to 90%) of all thyroid cancer cases. At the moment etiology of TC is not completely understood, with multiple genetic and epigenetic factor that are thought to be impo...

ea0099ep206 | Thyroid | ECE2024

Taking nothing for granted- Levothyroxine formulation

Samperi Irene , Bima Chiara , Radaelli Piero , Steffanini Mara , Chantal Ponziani Maria

Background: levothyroxine is the most common medication for the treatment of hypothyroidism. Usually, it is capable of restoring euthyroidism in most conditions. Absorption can be challenging, therefore different formulations are available (tablet, soft gel, liquid). Rarely it is necessary to use liothyronine to achieve normal TSH values.Clinical case: a 23 y/o woman was admitted to our outpatient clinic for severe hypothyroidism. She was diagnosed with ...

ea0081p416 | Pituitary and Neuroendocrinology | ECE2022

Cabergoline monotherapy in acromegaly – a multicenter, retrospective, cohort study of non-irradiated patients using current criteria for disease control

A Urwyler Sandrine , Samperi Irene , Lithgow Kirstie , Mavilakandy Akash , Matheou Mike , Ayuk John , Bradley Karin , Pal Aparna , Reddy Narendra , Karavitaki Niki

Background: Dopamine agonists (DA) are included in the management algorithm of acromegaly. Studies on cabergoline monotherapy report IGF-1 normalisation in between 0% and 100% of the patients during treatment periods ranging between 2.6 and 24 months. However, in many of these studies, previous radiotherapy is a confounding factor. Furthermore, real world data applying the current disease control criteria (normal IGF-1 and GH<1 mg/l) are not available. The aim of this stud...

ea0081rc5.8 | Rapid Communications 5: Diabetes, Obesity, Metabolism and Nutrition 2 | ECE2022

Attitude of Italian endocrinologists towards obesity management. Results of a survey with 534 respondents

Chianelli Marco , Eugenia Disoteo Olga , Giorgio Borretta , Attanasio Roberto , Persichetti Agnese , GRIMALDI FRANCO , Paoletta Agostino , Samperi Irene , Papini Enrico , Guglielmi Rinaldo , Scoppola Alessandro

Background: Obesity represents a threatening worldwide epidemic but, beyond the guidelines recommendations, its modalities of treatment in the medical community appear as variable and not clearly defined. Aim of our survey was to assess the present real-world approach to obesity management in Italy.Methods: Online anonymous survey among the 2248 members of the Italian Association of Clinical Endocrinologists (AME). The survey included 8 questions about d...

ea0086p88 | Neuroendocrinology and Pituitary | SFEBES2022

Cabergoline in acromegaly – a multicenter, retrospective, cohort study of non-irradiated patients using current criteria for disease control

Urwyler Sandrine A , Samperi Irene , Lithgow Kirstie , Mavilakandy Akash , Matheou Mike , Ayuk John , Bradley Karin , Pal Aparna , Reddy Narendra L , Karavitaki Niki

Background: Cabergoline monotherapy or in combination with somatostatin analogue (SSA) has been reported in few studies with IGF-1-normalization-rates 0%-100%(monotherapy) and 42%-60%(combination therapy). However, in these studies, inclusion of irradiated patients is a potential confounder and currently proposed disease control criteria (normal IGF-1, GH<1 mg/l) have not been applied.Aim: Investigate the efficacy of cabergoline monotherapy or as add...

ea0090p339 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Therapy of overweight and obesity resistant to behavioral treatment in the adult population with metabolic comorbidities. A network meta-analysis

Samperi Irene , Persichetti Agnese , Attanasio Roberto , Busetto Luca , Cinquini Michela , Paoletta Agostino , Papini Enrico , Novizio Roberto , Scoppola Alessandro , Vettor Roberto , Chianelli Marco

Background: Overweight and obesity are an increasing concern for public health worldwide. Obesity is a chronic, progressive and relapsing disease associated with the development of several comorbidities which may improve after weight loss. The first step in the management of weight excess includes life-style modifications but, in the long-term, obesity is frequently resistant to life-style changes only. Surgical procedures and medical treatments have, therefore, been developed...

ea0065p292 | Neuroendocrinology | SFEBES2019

Cabergoline in the treatment of acromegaly: experience from a large pituitary centre

Samperi Irene , Lithgow Kirstie , Chai Shu Teng , Asia Miriam , Ahmed Shahzada , Paluzzi Alessandro , Tsermoulas George , Meade Sara , Sanghera Paul , Toogood Andy , Gittoes Neil , Ayuk John , Karavitaki Niki

Introduction: Cabergoline is one of the medical treatments in acromegaly; it can be used alone or in combination with other available agents.Aim: To review the efficacy of cabergoline in patients with acromegaly treated in our centre.Patients and methods: Patients with acromegaly on cabergoline were identified from our Pituitary Registry. Clinical/laboratory/imaging data were collected and analysed.Results: F...

ea0092ps3-22-06 | Nodules 2 | ETA2023

Italian guideline on the management of benign non-hyperfunctioning thyroid nodule causing compressive symptoms

Novizio Roberto , Basile Michele , Scoppola Alessandro , Persichetti Agnese , Attanasio Roberto , Paoletta Agostino , Samperi Irene , Saulle Rosella , Vecchi Simona , Papini Enrico , behalf of all members of guideline panel On

Aim: Diagnostic definition and therapeutic interventions for nodular thyroid disease represent a high healthcare cost and their consequences may have a negative impact on quality of life of patients. This guideline aims at providing a reference for the management of non-functioning, benign thyroid nodules causing local symptoms in adults outside of pregnancy. The purpose is to standardize the treatment, based on the evidence provided by the GRADE method and the expertise of a ...

ea0092ps3-22-07 | Nodules 2 | ETA2023

A pharmacoeconomic analysis from italian guidelines for the management of non-hyperfunctioning, bening thyroid nodules

Samperi Irene , Basile Michele , scoppola alessandro , Persichetti Agnese , Attanasio Roberto , Paoletta Agostino , Saulle Rosella , Vecchi Simona , Novizio Roberto , Papini Enrico , behalf of all members of guideline panel on

Background: Thyroid nodules are the most common endocrine pathology. Due to the widespread use of imaging modalities, mostly ultrasound, the incidental finding of thyroid nodules has increased, reaching a prevalence of 50-60% in adults. Diagnostic definition and therapeutic interventions represent thus an increasing cost for health system. In patient with benign thyroid nodule causing local symptoms, hemithyroidectomy with isthmectomy or total thyroidectomy are the recommended...

ea0099p270 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Comparison between most recent guidelines about NAFLD medical treatment

Samperi Irene , Grasso Marco , Chantal Ponziani Maria , Carpenito Alberto , Tassone Francesco , Micaela Cuttica Carla , Egalini Filippo , Guido Roberta , Pisarro Morena , Buffardi Isabella , Nelva Anna

Background: Given the high prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in clinical endocrinology, diabetology, and primary care practice, international societies have addressed guidelines to drive clinicians in screening, diagnosis, and treatment for this condition.Aim: compare the most recent guidelines to address similarities and differences and help clinicians choosing the most updated evidence. We considered Italian guidelines (2021), AACE...